Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.

Valeria BuzzelliEmilia CarboneAntonia ManducaSara SchiaviAlessandro FeoJulia V PerederiyKyle H AmbertMarvin HausmanViviana Trezza

Published in: Psychopharmacology (2022)

These data support the hypothesis that serotonin-modulating drugs such as psilocybin may be useful to ameliorate ASD-related cognitive deficits. Overall, this study provides evidence of the beneficial effects of different schedules of psilocybin treatment in mitigating the short-term cognitive deficit observed in a rat model of FXS.

Keyphrases

autism spectrum disorder
attention deficit hyperactivity disorder
electronic health record
big data
case report
machine learning
drug induced
artificial intelligence
working memory
replacement therapy